India
Apr 28, 2025
Article and Study Summary: Article: Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis Published in: N Engl J Med. 2025;392(5):468–482. https://www.nejm.org/doi/full/10.1056/NEJMoa2400327 Authors: Guglielmetti L, Khan U, Velásquez GE, et...
Mar 5, 2024
Article and Study Summary: Antimicrobial stewardship and clinical pharmacist interventions in an Indian tertiary care hospital Published in: Journal of the American College of Clinical Pharmacy 2024;7:46-54...
May 27, 2021
Article: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis Published in: N Engl J Med. 2021;384(18):1705-1718. https://www.nejm.org/doi/full/10.1056/NEJMoa2033400 Authors: Dorman SE, Nahid P, Kurbatova EV, et al. Summary: The Tuberculosis...
Apr 29, 2021
Article: Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT...
Nov 16, 2020
Jennifer A Wagman, Adriane Wynn, Mika Matsuzaki, Natalia Gnatienko, Lisa R Metsch, Carlos Del Rio, Daniel J Feaster, Robin M Nance, Bridget M Whitney, Joseph A C Delaney, Shoshana Y Kahana, Heidi M Crane, Redonna K Chandler, Jennifer C Elliott, Frederick...